propranolol has been researched along with Arteriosclerosis Obliterans in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seven patients (5 with arteriosclerosis obliterans and 2 with Buerger's disease) completed a two-phase double-blind crossover trial of propranolol in intermittent claudication." | 9.04 | Controlled trial of propranolol in intermittent claudication. ( Adar, R; Gafni, J; Reichert, N; Shibolet, S, 1975) |
| "Ketanserin is a new strong antiserotoninergic drug that, unlike the previous ones, is selective for 5-hydroxytryptamine receptors." | 6.66 | Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs. ( Abrignani, MG; Adamo, L; Alaimo, G; Avellone, G; Cutietta, A; Giordano, U; Indovina, A; Novo, S; Pinto, A; Strano, A, 1986) |
| "Seven patients (5 with arteriosclerosis obliterans and 2 with Buerger's disease) completed a two-phase double-blind crossover trial of propranolol in intermittent claudication." | 5.04 | Controlled trial of propranolol in intermittent claudication. ( Adar, R; Gafni, J; Reichert, N; Shibolet, S, 1975) |
| "Ketanserin is a new strong antiserotoninergic drug that, unlike the previous ones, is selective for 5-hydroxytryptamine receptors." | 2.66 | Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs. ( Abrignani, MG; Adamo, L; Alaimo, G; Avellone, G; Cutietta, A; Giordano, U; Indovina, A; Novo, S; Pinto, A; Strano, A, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reichert, N | 1 |
| Shibolet, S | 1 |
| Adar, R | 1 |
| Gafni, J | 1 |
| Novo, S | 1 |
| Alaimo, G | 1 |
| Abrignani, MG | 1 |
| Giordano, U | 1 |
| Avellone, G | 1 |
| Pinto, A | 1 |
| Adamo, L | 1 |
| Cutietta, A | 1 |
| Indovina, A | 1 |
| Strano, A | 1 |
| Nicita-Mauro, V | 1 |
| Romeo, S | 1 |
| Arena, G | 1 |
2 trials available for propranolol and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
Controlled trial of propranolol in intermittent claudication.
Topics: Adult; Aged; Arteriosclerosis Obliterans; Clinical Trials as Topic; Humans; Intermittent Claudicatio | 1975 |
Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
Topics: Adult; Antihypertensive Agents; Arteriosclerosis Obliterans; Blood Coagulation; Blood Pressure; Doub | 1986 |
1 other study available for propranolol and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
[Effect of blocking of the adrenergic beta receptors with propranolol on peripheral arterial circulation in normal and pathological conditions: rheographic study].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arteries; Arteriosclerosis Obliterans; Blood Circulation; | 1968 |